Beyfortus

Active Ingredient(s): Nirsevimab-alip
FDA Approved: * July 17, 2023
Pharm Company: * ASTRAZENECA AB
Category: Antiviral
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Beyfortus 100 mg/ml Intramuscular Injection
NDC: 49281-574
Labeler:
Sanofi Pasteur Inc.
Beyfortus 50 mg/.5ml Intramuscular Injection
NDC: 49281-575
Labeler:
Sanofi Pasteur Inc.